Loading clinical trials...
Loading clinical trials...
Impact of Genetic Testing and Motivational Counseling on the Adherence to Healthy Lifestyle and Hypolipidemic Therapy and Efficiency of Cascade Screening in Patients With Familial Hypercholesterolemia (GENMOTIV-FH)
To date, there are highly effective lipid-lowering drugs, the combination of which makes it possible to achieve the target level of LDL-C in most patients with familial hypercholesterolemia (FH). However, the effectiveness of treatment of FH patients strongly depends on adherence to lipid-lowering therapy and to the healthy lifestyle, as well as the detection of the disease and the therapy prescription as early as possible, better in childhood. The aim of the study is to assess the impact of genetic testing and motivational counseling on the effectiveness of treatment and cascade screening in patients with FH.
There are several tasks of the study: 1. To assess the effect of knowledge of patients with FH about the result of their FH genetic testing on the adherence to a healthy lifestyle and hypolipidemic therapy. 2. To assess the impact of knowledge of patients with FH about the result of their FH genetic testing on the effectiveness of cascade screening. 3. To assess the influence of motivational counseling of patients with FH on the adherence to a healthy lifestyle and hypolipidemic therapy. 4. To assess the impact of motivational counseling of patients with FH on the effectiveness of cascade screening.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
National Medical Research Centre for Therapy and Preventive Medicine of the Ministry of Health of Russia
Moscow, Russia
Start Date
June 15, 2020
Primary Completion Date
January 30, 2025
Completion Date
March 30, 2025
Last Updated
December 17, 2024
180
ESTIMATED participants
Genetic Testing
GENETIC
Motivational Counseling
BEHAVIORAL
Lipid analysis
DIAGNOSTIC_TEST
Consultation with a cardiologist-lipidologist (correction of therapy, lifestyle, diet)
OTHER
Visit 1
OTHER
Visit 2
OTHER
Visit 3
OTHER
Visit 4
OTHER
Lead Sponsor
National Medical Research Center for Therapy and Preventive Medicine
Collaborators
NCT06555120
NCT01375751
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT03018678